loading

Finanzdaten der Jazz Pharmaceuticals Plc-Aktie (JAZZ)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
16.47%
1,045.71
897.84 1,088.17 1,054.97 1,023.83
Operating Expenses
81.61%
1,732.10
953.73 897.40 794.76 824.38
Benefits Costs and Expenses
76.77%
1,781.27
1,007.65 954.95 854.16 885.90
Costs And Expenses
81.61%
1,732.10
953.73 897.40 794.76 824.38
Operating Income/Loss
1,128%
-686.39
-55.89 190.77 260.21 199.44
Income/Loss Before Equity Method Investments
569.84%
-735.55
-109.81 133.22 200.81 137.93
Income/Loss From Equity Method Investments
84.13%
-0.086
-0.542 -0.016 -0.285 -0.012
Income/Loss From Continuing Operations Before Tax
569.84%
-735.55
-109.81 133.22 200.81 137.93
Income Tax Expense/Benefit, Deferred
51.53%
-66.42
-43.83 -2.355 -64.40 -75.18
Income Tax Expense/Benefit
3.60%
-17.17
-17.81 -57.91 -14.53 -30.65
Income/Loss From Continuing Operations After Tax
676.29%
-718.38
-92.54 191.13 215.34 168.57
Net Income/Loss
676.38%
-718.47
-92.54 191.12 215.06 168.57
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.35%
61.19
60.98 -0.437 61.41 62.88
Diluted Average Shares
0.35%
61.19
60.98 -1.504 63.17 69.62
Basic Earnings Per Share
672.37%
-11.74
-1.52 3.13 3.50 2.68
Diluted Earnings Per Share
672.37%
-11.74
-1.52 3.02 3.42 2.49
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$24.75
price up icon 0.92%
$84.63
price up icon 0.77%
$25.04
price down icon 7.14%
$103.63
price down icon 0.75%
$133.06
price up icon 0.90%
biotechnology ONC
$299.15
price down icon 3.29%
Kapitalisierung:     |  Volumen (24h):